Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase
Open Access
- 14 May 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5), 1468
- https://doi.org/10.3390/jcm9051468
Abstract
Background: Multiple sclerosis (MS) is a neurodegenerative disease that affects the central nervous system. The cause of MS is still unknown, and the role of innate immunity is still poorly understood. Objective: The goal of this study was to understand whether, compared to healthy controls, the elements of innate immunity are altered in the blood of MS patients in the remitting phase. Methods: A total of 77 naïve MS patients and 50 healthy controls were included in this cohort study. Peripheral blood samples were collected and analyzed. All the calculations were performed with the statistical system R (r-project.org). Results: The results showed that MS patients had significantly lower relative representations of granulocytes than healthy controls, while the relative representations of monocytes remained unchanged. CD64- and PD-L1-positive granulocytes exhibited a nonsignificant decreasing trend, while granulocytes with other membrane markers remained noticeably unchanged. Conclusion: The results of this study suggest that studies of the causes of MS and its treatment should also be focused on the elements of the innate immune response.This publication has 49 references indexed in Scilit:
- An Update in the Use of Antibodies to Treat Glioblastoma MultiformeAutoimmune Diseases, 2013
- Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune ResponseJournal of Immunology Research, 2013
- Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patientscclm, 2012
- Oxidative damage in multiple sclerosis lesionsBrain, 2011
- Mouse models for multiple sclerosis: Historical facts and future implicationsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Role of the innate immune system in the pathogenesis of multiple sclerosisJournal of Neuroimmunology, 2010
- Innate immunityJournal of Allergy and Clinical Immunology, 2010
- Younger children with MS have a distinct CSF inflammatory profile at disease onsetNeurology, 2010
- Granulocytes: effector cells or immunomodulators in the immune response to helminth infection?Parasite Immunology, 2010
- B7‐H1 restricts neuroantigen‐specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosisEuropean Journal of Immunology, 2008